Use of Rituximab Compared to Anti-TNF Agents As Second and Third Line Therapy in Patients with Rheumatoid Arthritis: 6-Year Follow-up Report from the Rhumadata® Clinical Database and Registry

被引：0
|
作者：
Choquette, Denis [1 ]
Bessette, Louis [2 ]
Haraoui, Boulos [1 ]
Massicotte, Frederic [1 ]
Pelletier, Jean-Pierre [1 ]
Raynauld, Jean-Pierre [1 ]
Remillard, Marie-Anais [3 ]
Sauvageau, Diane [1 ]
Villeneuve, Edith [1 ]
Coupal, Louis [1 ]
Brown, Jacques [4 ]
Turcotte, Angele [4 ]
机构：
[1] IRRM, Rheumatol, Montreal, PQ, Canada
[2] CORQ, Quebec City, PQ, Canada
[3] IRRM, Rhumatol, Montreal, PQ, Canada
[4] CORQ, Rheumatol, Quebec City, PQ, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
428
引用
收藏
页数：2
相关论文
共 47 条
  • [1] USE OF RITUXIMAB COMPARED TO ANTI-TNF AGENTS AS SECOND AND THIRD-LINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS. A 6-YEAR FOLLOW-UP REPORT FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY
    Raynauld, J. -P.
    Bessette, L.
    Brown, J.
    Coupal, L.
    Haraoui, B.
    Massicotte, F.
    Pelletier, J. -P.
    Remillard, M. -A.
    Sauvageau, D.
    Villeneuve, E.
    Choquette, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 190 - 190
  • [2] Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A 6 Year Follow-Up Report from the Rhumadata Clinical Database and Registry
    Choquette, Denis
    Bessette, Louis
    Brown, Jacques
    Haraoui, Boulos
    Massicotte, Frederic
    Pelletier, Jean-Pierre
    Raynauld, Jean-Pierre
    Remillard, Marie-Anais
    Sauvageau, Diane
    Villeneuve, Edith
    Coupal, Louis
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1212 - 1213
  • [3] Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis: A Report from the RHUMADATA® Clinical Database and Registry
    Choquette, Denis
    Bessette, Louis
    Fortin, Isabelle
    Haraoui, Boulos
    Pelletier, Jean-Pierre
    Raynauld, Jean-Pierre
    Remillard, Marie-Anais
    Massicotte, Frederic
    Sauvageau, Diane
    Villeneuve, Edith
    Coupal, Louis
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1298 - 1298
  • [4] Use of Rituximab Compared to Anti-Tnf Agents As Second and Third Line Therapy in Patients with Rheumatoid Arthritis: A Report from the rhumadata® Clinical Database and registry.
    Choquette, Denis
    Raynauld, Jean-Pierre
    Pelletier, Jean Pierre
    Haraoui, Boulos
    Bessette, Louis
    Villeneuve, Edith
    Remillard, Marie-Anais
    Fortin, Isabelle
    Sauvageau, Diane
    Coupal, Louis
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S676 - S676
  • [5] USE OF RITUXIMAB COMPARED TO ANTI-TNF AGENTS AS SECOND AND THIRD LINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS. A REPORT FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY
    Choquette, D.
    Raynauld, J. -P.
    Bessette, L.
    Fortin, I.
    Haraoui, B.
    Pelletier, J. P.
    Remillard, M. -A.
    Sauvageau, D.
    Villeneuve, E.
    Coupal, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 881 - 881
  • [6] Use Of Rituximab As Second Line Biologic Agent Compared With Adalimumab, Etanercept and Infliximab In Patients With Rheumatoid Arthritis. A Report From The Rhumadata® Clinical Database and Registry
    Bessette, Louis
    Choquette, Denis
    Sauvageau, Diane
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Villeneuve, Edith
    Coupal, Louis
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S187 - S187
  • [7] Better Retention Rate of Rituximab Vs Anti-Tnf Agents As Second Line therapy in RA Patients Failing a First Anti-Tnf Agents: Results From the Rhumadata® Registry
    Choquette, D.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S859 - S859
  • [8] MODELING THE COST-EFFECTIVENESS OF RITUXIMAB USE COMPARED TO TUMOR NECROSIS FACTOR INHIBITORS (ANTI-TNF) AGENTS AS A SECOND-LINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN QUEBEC, CANADA USING RHUMADATA REGISTRY DATA
    Lopatina, E.
    Marshall, D. A.
    Coupal, L.
    Choquette, D.
    VALUE IN HEALTH, 2017, 20 (05) : A147 - A147
  • [9] Modeling the Cost-effectiveness of Rituximab Use Compared to Tumor Necrosis Factor Inhibitors (anti-TNF) Agents as a Second-line Therapy in Patients with Rheumatoid Arthritis (RA) in Quebec, Canada Using RHUMADATA Registry Data
    Lopatina, Elena
    Choquette, Denis
    Coupal, Louis
    Marshall, Deborah
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 882 - 883
  • [10] Comparing abatacept to Adalimumab, Etanercept and Infliximab As First Or Second Line Agents in Patients With Rheumatoid arthritis: Experience From the rhumadata® Clinical Database and Registry
    Choquette, Denis
    Sauvageau, Diane
    Bessette, Louis
    Haraoui, Boulos
    Pelletier, Jean Pierre
    Raynauld, Jean-Pierre
    Villeneuve, Edith
    Coupal, Louis
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S186 - S186
12345